Although at this stage the upstream mediators inducing NF-κB in this context remain elusive, several pathways have been implicated in driving tumor-promoting NF-κB activity in cancer, such as other members of the TNF receptor superfamily, growth factor receptors, replicative stress and DNA damage [50]. The gene discussed is NFKB1; the disease is cancer.